-
AAPP 2026 Schedule
Enjoy browsing through all that the AAPP 2026 Annual Meeting has to offer!
L1 = Level 1
L2 = Level 2
L3 = Level 3
LOOK CLOSELY at the time zone drop down! In-person attendees should have their time zone set to PDT (Pacific Daylight Time).
Customize your schedule by bookmarking sessions of interest using the bookmark () buttons. Then, click the button below to only show your bookmarks.
Sunday, April 19, 2026
-
-
-
Industry Showcase | Supported by Bristol Myers Squibb | A Critical Moment in Schizophrenia Care: The Inpatient Opportunity
Free Public Registration
Jacob Hanaie, PharmD, APh
Regency Ballroom (L2)
-
-
The Pleasure Pain Balance in a Dopamine Overloaded World | Supported by the AAPP Foundation
ACPE
Anna Lembke, MD
ACPE #: 0284-0000-26-014-L01-P (Knowledge) (1.00 hour)
Grand Ballroom (L2)
-
Real World/Practical Insights in New Medications
ACPE
Kevin Kavanagh, PharmD, BCPP, Aph; Hejab J. Khan, PharmD, BCPP; Hannah Wilkoff, PharmD, BCPP
ACPE #: 0284-0000-26-015-L01-P (Knowledge) (1.00 hour)
Grand Ballroom (L2)
-
Beyond Childhood: Management of Autism Spectrum Disorder in Adults
ACPE
Gary Stobbe, MD
ACPE #: 0284-0000-26-016-L01-P (Knowledge) (1.00 hour)
Grand Ballroom (L2)
-
Judith J. Saklad Memorial Award Presentation & AAPP Forum On Our Future
Free Public Registration
Grand Ballroom (L2)
Monday, April 20, 2026
-
Industry Showcase | Supported by Teva Pharmaceuticals | Tardive Dyskinesia: Considerations in the Pharmacy Setting
Free Public Registration
Hany Mohamed, PharmD, RPh, BCGP, BCPP
Regency Ballroom (L2)
-
Repurposing GLP-1 Receptor Agonists for Substance Use Disorders
ACPE
Stephanie Weiss, MD, PhD
ACPE #: 0284-0000-26-017-L01-P (Knowledge) (1.00 hour)
Grand Ballroom (L2)
-
Beyond the Price Tag: Cost-Effectiveness of Today’s Psychotropic Medications
ACPE
BCPP
Vera Reinstein, PharmD, BCPS, FNCAP
ACPE #: 0284-0000-26-018-L04-P (Application) (1.25 hours)
Grand Ballroom (L2)
-
Industry Showcase | Supported by AbbVie | Managing Depressive, Acute Manic & Mixed Episodes Associated with Bipolar I Disorder In Adults
Free Public Registration
Gregory W. Mattingly, MD
Regency Ballroom (L2)
-
Overdose Prevention Centers: Research, Outcomes, and Clinical Relevance
ACPE
Brandon D.L. Marshall, PhD
ACPE #: 0284-0000-26-020-L04-P (Knowledge) (1.00 hour)
GB A-D (L2)
-
Navigating Early Psychosis: Strategies for Optimal Antipsychotic Treatment Selection
ACPE
BCPP
Deepak K. Sarpal, MD
ACPE #: 0284-0000-26-019-L01-P (Application) (1.25 hours)
GB E-K (L2)
-
-
Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings
ACPE
Stephen Soumerai, ScD
ACPE #: 0284-0000-26-022-L01-P (Knowledge) (1.00 hour)
GB A-D (L2)
-
Never Let a Good Crisis Go to Waste: What Pharmacists Need to Understand about Helping People in Crisis
ACPE
BCPP
Jack Rozel, MD, MSL, DFAPA
ACPE #: 0284-0000-26-021-L04-P (Application) (1.25 hours)
GB E-K (L2)
-
-
Reshaping Perspectives: The Link Between Stigma and Health Inequities in Mental Health
ACPE
Carolanne Wartman, PharmD, BCPS, BCPP
ACPE #: 0284-0000-26-024-L99-P (Knowledge) (1.00 hour)
GB A-D (L2)
-
Deprescribing Psychotropics in Older Adults with Neuropsychiatric Disorders
ACPE
BCPP
Nina Vadiei, PharmD, BCPP
ACPE #: 0284-0000-26-023-L01-P (Application) (1.25 hours)
GB E-K (L2)
-
-
Industry Showcase | Supported by Teva Pharmaceuticals | The Role of UZEDY in Schizophrenia Treatment: A Clinical Perspective
Free Public Registration
Jacob Hanaie, PharmD, APh
Regency Ballroom (L2)
Tuesday, April 21, 2026
-
Midlife Mood Management: A Pharmacy-Led Approach to Menopausal Mental Health
ACPE
Lisa Miller, PharmD, MSCP, LCMHCA, NCC
ACPE #: 0284-0000-26-025-L01-P (Knowledge) (1.00 hour)
Grand Ballroom (L2)
-
Navigating Real Challenges: Applying Artificial Intelligence to Personalized Treatment Planning in Mental Health
ACPE
BCPP
Andrea Sikora, PharmD, MSCR, FCCP, FCCM
ACPE #: 0284-0000-26-026-L99-P (Application) (1.25 hours)
Grand Ballroom (L2)
-
Industry Showcase | Supported by Johnson & Johnson | Challenges in Achieving Symptom Control in Major Depressive Disorder: Considering Adjunctive Treatment Options
Free Public Registration
Margaret Martin, PharmD, BCPS
Regency Ballroom (L2)
-
-
Clinical Pearls
ACPE
Katie Bye, PharmD; Melanie Rovelo, PharmD, BCPP; Makenzie Harrison, PharmD, BCPP
ACPE #: 0284-0000-26-028-L01-P (Knowledge) (1.00 hour)
GB A-D (L2)
-
The Hidden Hangover: Managing Alcohol Use Disorder with Co-occurring Trauma
ACPE
BCPP
Theresa Frey, PharmD, BCPP
ACPE #: 0284-0000-26-027-L01-P (Application) (1.25 hours)
GB E-K (L2)
-
-
Stick with It: An Update on New Long-Acting Injectable Antipsychotics
ACPE
Andy Williams, PharmD, BCPP, FAAPP
ACPE #: 0284-0000-26-030-L01-P (Knowledge) (1.00 hour)
GB A-D (L2)
-
Medication Treatment of Social Anxiety Disorder: Beyond Serotonin Reuptake Inhibitors
ACPE
BCPP
Franklin Schneier, MD
ACPE #: 0284-0000-26-029-L01-P (Application) (1.25 hours)
GB E-K (L2)
-
-
Differences in Non-Suicidal Self-Injury (NSSI), Passive and Active Suicidal Ideation
ACPE
Ashley Perkins, PharmD, EdS, CPh
ACPE #: 0284-0000-26-032-L01-P (Knowledge) (1.00 hour)
GB A-D (L2)
-
The Mind-Body Connection: Integrating Psychiatric and Holistic Care in Fibromyalgia Management
ACPE
BCPMP
BCPP
Emily Leppien, PharmD, BCPS, BCPP
ACPE #: 0284-0000-26-031-L08-P (Application) (1.25 hours)
GB E-K (L2)
-
Wednesday, April 22, 2026
-
The Buprenorphine Bulletin: Navigating Updates to Prescribing
ACPE
Zachary Hill, PharmD, BCPP, MA
ACPE #: 0284-0000-26-033-L01-P (Knowledge) (1.00 hour)
Grand Ballroom (L2)
-
Guideline Updates for the Psychiatric Pharmacist
ACPE
Lindsey Garner, PharmD, MBA, BCPS, BCPP
ACPE #: 0284-0000-26-034-L01-P (Knowledge) (1.00 hour)
Grand Ballroom (L2)
-
Psychiatric and Neurologic Medication Pipeline
ACPE
Stephen R. Saklad, PharmD, BCPP, FAAPP
ACPE #: 0284-0000-26-035-L01-P (Knowledge) (1.00 hour)
Grand Ballroom (L2)